These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31540557)

  • 1. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.
    Saunders A; Messer LH; Forlenza GP
    Expert Rev Med Devices; 2019 Oct; 16(10):845-853. PubMed ID: 31540557
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTEGRATED INSULIN PUMP AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGY IN DIABETES CARE TODAY: A PERSPECTIVE OF REAL-LIFE EXPERIENCE WITH THE MINIMED
    Aleppo G; Webb KM
    Endocr Pract; 2018 Jul; 24(7):684-692. PubMed ID: 30048171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The artificial pancreas.
    Boughton CK; Hovorka R
    Curr Opin Organ Transplant; 2020 Aug; 25(4):336-342. PubMed ID: 32618719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review.
    Mameli C; Smylie GM; Galati A; Rapone B; Cardona-Hernandez R; Zuccotti G; Delvecchio M
    Eur J Pediatr; 2023 May; 182(5):1949-1963. PubMed ID: 36809498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiniMed
    McVean J; Miller J
    Expert Rev Med Devices; 2021 Jun; 18(6):499-504. PubMed ID: 34014794
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.
    Dadlani V; Pinsker JE; Dassau E; Kudva YC
    Curr Diab Rep; 2018 Aug; 18(10):88. PubMed ID: 30159816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.
    Zhou K; Isaacs D
    Curr Cardiol Rep; 2022 Sep; 24(9):1159-1167. PubMed ID: 35727409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New technologies in diabetes treatment].
    Serfling G; Kalscheuer H; Schmid SM; Lehnert H
    Internist (Berl); 2019 Sep; 60(9):912-916. PubMed ID: 31375851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast-Acting Insulin Aspart Use with the MiniMed
    Hsu L; Buckingham B; Basina M; Ekhlaspour L; von Eyben R; Wang J; Lal RA
    Diabetes Technol Ther; 2021 Jan; 23(1):1-7. PubMed ID: 32520594
    [No Abstract]   [Full Text] [Related]  

  • 16. A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery.
    Ekhlaspour L; Tabatabai I; Buckingham B
    J Diabetes Sci Technol; 2019 Jul; 13(4):645-663. PubMed ID: 31130007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study.
    Forlenza GP; Vigers T; Berget C; Messer LH; Lal RA; Basina M; Maahs DM; Hood K; Buckingham B; Wilson DM; Wadwa RP; Driscoll KA; Pyle L
    Diabetes Technol Ther; 2022 Mar; 24(3):157-166. PubMed ID: 34780306
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol.
    de Bock M; McAuley SA; Abraham MB; Smith G; Nicholas J; Ambler GR; Cameron FJ; Fairchild JM; King BR; Geelhoed EA; Davis EA; O'Neal DN; Jones TW;
    BMJ Open; 2018 Aug; 8(8):e020275. PubMed ID: 30104309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMed
    Grosman B; Wu D; Parikh N; Roy A; Voskanyan G; Kurtz N; Sturis J; Cohen O; Ekelund M; Vigersky R
    Comput Methods Programs Biomed; 2021 Jun; 205():106087. PubMed ID: 33873075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.